FERMENTALG (EPA:FALG)

PRESS RELEASE

published on 10/03/2024 at 18:00, 1 year 3 months ago

Sales of EUR 9.7 million to end September, in line with 2024 full-year target
Fermentalg reports unaudited sales of €9.7 million at end of September 2024, tripled from previous year. Maintains sales target of around €12 million for 2024 despite market challenges. Exhibiting at upcoming industry events

Sales Growth Industry Events FERMENTALG Microalgae
BRIEF

published on 09/17/2024 at 18:05, 1 year 4 months ago

Fermentalg Sees Strong H1 2024 Performance with Strategic Growth

FERMENTALG HuvePharma H1 2024 Results DHA Origins® EverzureTM
PRESS RELEASE

published on 09/17/2024 at 18:00, 1 year 4 months ago

A 1st half-year 2024 marked by the success of the commercial relaunch and the strengthening of strategic alliances
Fermentalg presents strong 1st half-year 2024 results with a 2.7-fold increase in sales. Strategic partnerships boost sales and manufacturing performance. Cash position up by €10 million

Financial Results Strategic Partnerships Sales Increase FERMENTALG Microalgae
BRIEF

published on 09/11/2024 at 18:05, 1 year 4 months ago

Fermentalg: Information on the Total Number of Voting Rights and Shares

Share Capital Voting Rights Actions Publication FERMENTALG
BRIEF

published on 08/26/2024 at 19:35, 1 year 5 months ago

Fermentalg: Information on Voting Rights and Shares

Voting Rights Actions AMF Financial Publication FERMENTALG
BRIEF

published on 07/31/2024 at 07:35, 1 year 5 months ago

Fermentalg: General meeting on September 17, 2024

General Assembly Increase In Capital FERMENTALG Industrial Partnership HuvePharma
BRIEF

published on 07/10/2024 at 18:05, 1 year 6 months ago

FERMENTALG: Information on voting rights and shares

Voting Rights Actions AMF Publication FERMENTALG
BRIEF

published on 07/04/2024 at 18:05, 1 year 6 months ago

Fermentalg records record turnover of €6.3 million in the first half of 2024

Partnership Turnover FERMENTALG HuvePharma Marine Biotechnology
PRESS RELEASE

published on 07/04/2024 at 18:00, 1 year 6 months ago

Thanks to sales of EUR6.3 million, Fermentalg closes a historic 1st half-year 2024, also marked by its strategic agreement with HuvePharma
Fermentalg reports strong sales growth in H1 2024, exceeding targets. Partners with HuvePharma for sustainable solutions. Annual sales target raised to €12M. Strategic alliance for a competitive, sustainable supply

Sustainable Solutions Sales Growth FERMENTALG HuvePharma H1 2024
BRIEF

published on 07/02/2024 at 18:35, 1 year 6 months ago

Half-yearly review of the liquidity contract between Fermentalg and Gilbert Dupont

Liquidity Contract Actions Gilbert Dupont Half-year Results FERMENTALG

Published on 01/30/2026 at 14:00, 2 hours 14 minutes ago

CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 7 hours 39 minutes ago

Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 8 hours 14 minutes ago

Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 13 hours 59 minutes ago

Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 16 hours 14 minutes ago

LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies

View all ACCESSWIRE

Published on 01/30/2026 at 16:00, 14 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Dauch Corporation
Published on 01/30/2026 at 15:59, 15 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/30/2026 at 15:58, 16 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Glencore plc
Published on 01/30/2026 at 15:57, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/30/2026 at 15:56, 17 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc

View all EQS

Published on 01/30/2026 at 08:00, 8 hours 14 minutes ago

AMA: 4th Quarter & FY 2025 Revenues
Published on 01/29/2026 at 18:00, 22 hours 14 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 22 hours 29 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 22 hours 29 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 22 hours 34 minutes ago

ALTEN: Annual revenue 2025

View all LES ECHOS COMFI WIRE

News